- Joined
- Aug 2, 2022
- Messages
- 107,592
- Reaction score
- 3
- Points
- 38
![88b5a028e2e3136e481c4cec37b18728.png](https://i6.imageban.ru/out/2024/02/29/88b5a028e2e3136e481c4cec37b18728.png)
2023 | ISBN: 0889376328 | English | 555 pages | True PDF | 4 MB
Description:
Quick and comprehensive information on psychotropic drugs for adults.
- Accurate and up-to-date
- Comparison charts help decision-making
- Icons and full color
- Available in print and online
- Downloadable patient info sheets
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists,physicians, pharmacists, nurses, and other mental health professionals.
• Independent, unbiased, up-to-date
• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions.) for a quick overview of treatment options
• Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug
• Potential interactions and side effects summarized in comparison charts
• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• Clearly written patient information sheets available for download as printable PDF files
This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.
New in this edition
• Antidepressants chapter includes a new section on the NMDA receptor antagonist/CYP2D6 inhibitor combination product (dextromethorphan/bupropion; Auvelity extended-release tablets)
• Antipsychotics updates include revised Clozapine monitoring tables which now also contain monitoring requirements for patients with or without non-benign ethnic neutropenia
• Mood Stabilisers sections on Lithium and Anticonvulsants extensively revised
• Dementia chapter includes a new section on Lecanemab (Leqembi), a fast-track FDA approved treatment for Alzheimer's disease
• Treatment of Substance Use Disorders includes revisions to Buprenorphine dosing section to include a rapid micro-induction method (Bernese method) that allows treatment to start without waiting for patient to be in withdrawal
• Unapproved treatments of Psychiatric Disorders, Natural Health Products, and Pharmacogenetic chapters all substantially revised
• New formulations and trade names include: Invega Hafyera (paliperidone long-acting 6-monthly IM injection), Subutex (buprenorphine sublingual tablets), Quviviq (daridorexant tablets)
![Sun with face :sun_with_face: 🌞](https://cdn.jsdelivr.net/joypixels/assets/6.6/png/unicode/64/1f31e.png)
![Pushpin :pushpin: 📌](https://cdn.jsdelivr.net/joypixels/assets/6.6/png/unicode/64/1f4cc.png)
![vAvBU3y.gif](https://i.postimg.cc/VkSJ5scZ/vAvBU3y.gif)
![Star :star: ⭐](https://cdn.jsdelivr.net/joypixels/assets/6.6/png/unicode/64/2b50.png)
![Check mark button :white_check_mark: ✅](https://cdn.jsdelivr.net/joypixels/assets/6.6/png/unicode/64/2705.png)
NitroFlare Link(s)
Code:
https://nitroflare.com/view/0DC2C7BA5EC7976/Clinical.Handbook.Of.Psychotropic.Drugs.25th.Edition.rar
RapidGator Link(s)
Code:
https://rapidgator.net/file/837f0e86a7695c14a61c6ee0a7fa4cd1/Clinical.Handbook.Of.Psychotropic.Drugs.25th.Edition.rar